Issue #3 2016 – Digital edition
Posted: 30 June 2016 | European Pharmaceutical Review | 3 comments
In this issue: Biosimilars, Regulation, Packaging, Microfluidics, Microbiology, PAT, Antibiotic Resistance, and much more…
- FOREWORD – Biosimilars: future prospects
David P. Elder, JPAG chair and Consultant - REGULATORY INSIGHT: Pharma sector – long a target for antitrust enforcers
Diarmuid Ryan and Martin Rees, Squire Patton Boggs - IN-DEPTH FOCUS: PACKAGING
With articles from Martin Sawer, Healthcare Distribution Association, Maarten Van Baelen and Johan Verhaeghe, Medicines for Europe and Micael Lopes and Michael A. Graf, Deloitte Consulting - MICROFLUIDICS: Microfluidics in cell-to-cell signalling measurements
Laura D. Casto and Christopher A. Baker, University of Tennessee - IN-DEPTH FOCUS: MICROBIOLOGY
With articles from David Elder and Paul Newby, GlaxoSmithKline and Tim Sandle, Bio Products Laboratory. Plus a microbiology roundtable - PAT SERIES: Recent achievements in NIR-based on-line monitoring of lyophilisation processes
Adrian Funke, Bayer Pharma AG, Reinhard Gross, Stephan Tosch and Albert Tulke, Bayer Technology GmbH - ANTIBIOTIC RESISTANCE: Interview with Bjorn Herpers, Micreos
The digital version of Issue #3 2016 is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Good coverage and contents of Bio similars, welcome.
I am from Russia. I work at Servier.
THANK U